Loading…

Browse All Grants

20,252 grants found

Filters
Reset

Showing 4,1214,140 of 20,252 grants

Completed NON-SBIR/STTR RPGS
Targeting intracrine steroidogenesis in anti-androgen resistant prostate cancer
NATIONAL CANCER INSTITUTE University of California At Davis United States 2023 – 2025

PROJECT ABSTRACT Prostate cancer (PCa) is the second leading cause of cancer related death in men in the United States in 2022. A limit number of PCa cell lines and patient-derived...

$2.24M
USD
Active NON-SBIR/STTR RPGS
Integrating imaging and biopsy-derived molecular markers for the pre-surgical detection of indolent and aggressive early stage lung adenocarcinoma
NATIONAL CANCER INSTITUTE Boston University Medical Campus United States 2023 – 2028

ABSTRACT Lung adenocarcinoma (LUAD) is the most common lung cancer subtype diagnosed in the US; characterized by a broad spectrum of biological behaviors and clinical trajectories....

$6.08M
USD
Active NON-SBIR/STTR RPGS
Mechanisms of mutant p53 reactivation
NATIONAL CANCER INSTITUTE University of California-Irvine United States 2023 – 2028

PROJECT SUMMARY The tumor suppressor protein p53 is the most frequently mutated protein in human cancers. About 600,000 new cancer patients in the United States are diagnosed each...

$5.37M
USD
Active NON-SBIR/STTR RPGS
Dietary fatty acids drive pancreatic cancer development
NATIONAL CANCER INSTITUTE Yale University United States 2023 – 2028

PROJECT SUMMARY/ABSTRACT Despite significant advances in cancer care, pancreatic ductal adenocarcinoma (PDAC) remains the third leading cause of cancer death in the United States w...

$5.34M
USD
Completed NON-SBIR/STTR RPGS
siRNA-based Gold Nanoparticles as a Therapeutic Enhancer for Triple Negative Breast Cancer (TNBC) Radiotherapy
NATIONAL CANCER INSTITUTE Henry Ford Health System United States 2023 – 2025

ABSTRACT Radiation therapy (RT) modulates immunological properties of tumor microenvironment (TME) to stimulate antitumor immune response. However, RT initiates immunosuppressive m...

$762.3K
USD
Active NON-SBIR/STTR RPGS
Deciphering the role of NELFE in modulating MYC signaling in HCC
NATIONAL CANCER INSTITUTE Thomas Jefferson University United States 2023 – 2028

ABSTRACT Hepatocellular carcinoma (HCC) is an aggressive tumor type with poor prognosis due to the diverse etiology, tumor heterogeneity, and the frequent late stage diagnosis. HCC...

$3.38M
USD
Active NON-SBIR/STTR RPGS
Substrate Specificity Determinants in Nutrient Solute Carrier Transporters
NATIONAL CANCER INSTITUTE Icahn School of Medicine At Mount Sinai United States 2023 – 2028

SUMMARY Alterations in cell metabolism support rapid growth and proliferation of cells in pathologies such as cancer, au- toimmune disease, and heart ischemia, resulting in increas...

$4.02M
USD
Active NON SBIR/STTR CONTRACTS
Colorectal Cancer (CRC) Prevention by Urolithin A in Rodent CRC models
NATIONAL CANCER INSTITUTE Research Inst of Fox Chase Can Ctr United States 2023 – 2026

Colorectal cancer (CRC) is the third most common cancer diagnosed in the United States as per the current estimates of The American Cancer Society.The number of CRC cases in the Un...

$10.39M
USD
Active NON-SBIR/STTR RPGS
Dietary fatty acids drive pancreatic cancer development
NATIONAL CANCER INSTITUTE Yale University United States 2023 – 2028

PROJECT SUMMARY/ABSTRACT Despite significant advances in cancer care, pancreatic ductal adenocarcinoma (PDAC) remains the third leading cause of cancer death in the United States w...

$1.84M
USD
Active NON-SBIR/STTR RPGS
The Role of Mortalin in Thyroid Cancer
NATIONAL CANCER INSTITUTE Medical College of Wisconsin United States 2023 – 2028

The goal of this project is to elucidate the mechanism by which mortalin is upregulated in thyroid cancer, determine the role of mortalin for tumor cell metabolism, and evaluate th...

$4.1M
USD
Completed NON-SBIR/STTR RPGS
Targeting FASN to eliminate metastatic breast cancer in the brain
NATIONAL CANCER INSTITUTE University of Toledo Health Sci Campus United States 2023 – 2025

Summary Metastatic breast cancer in the brain is a deadly disease and the second most tumor incidence in the central nervous system. Although improvement of cancer treatments with...

$1.81M
USD
Completed NON-SBIR/STTR RPGS
PIK3CA signaling and pancreatic cancer
NATIONAL CANCER INSTITUTE State University New York Stony Brook United States 2023 – 2025

The goal of this proposal is to explore how to target PIK3CA signaling for treatment of pancreatic ductal adenocarcinoma (PDAC). This deadly cancer is highly resistant to current t...

$2.21M
USD
Active NON-SBIR/STTR RPGS
Characterization of the Regulation and Gene Targets of TBX2 in Rhabdomyosarcoma
NATIONAL CANCER INSTITUTE Southern Illinois University Carbondale United States 2023 – 2026

My lab is focused on understanding the molecular events that result in the transition of a skeletal muscle precursor cell to a rhabdomyosarcoma (RMS) tumor cell in hopes to suggest...

$4.46M
USD
Active NON-SBIR/STTR RPGS
Assessing residential neighborhood exposome exposures and the associations with cancer incidence
NATIONAL CANCER INSTITUTE Virginia Commonwealth University United States 2023 – 2028

Colorectal, lung, and female breast cancers are major public health burdens and there are clear geographic and racial/ethnic disparities in their incidence. Each of these cancers h...

$3.72M
USD
Completed NON-SBIR/STTR RPGS
Mechanisms promoting copper dependent cell death in cancer
NATIONAL CANCER INSTITUTE Broad Institute, Inc United States 2023 – 2023

PROJECT SUMMARY Copper is an essential co-factor for enzymes across the animal kingdom yet even modest intracellular concentrations can be toxic, resulting in cell death. The toxic...

$5.9M
USD
Active NON-SBIR/STTR RPGS
3' tsRNAs: biologic function and pre-clinical targeting for treating human disease
NATIONAL CANCER INSTITUTE Stanford University United States 2023 – 2028

ABSTRACT Over the last decade we characterized and studied the properties of various tRNA derived small RNAs (tsRNAs). In recent years, we have focused on one class commonly referr...

$5.46M
USD
Active NON-SBIR/STTR RPGS
A Biobehavioral Intervention to Reduce Adverse Outcomes in Young Adult Testicular Cancer Survivors
NATIONAL CANCER INSTITUTE University of California-Irvine United States 2023 – 2028

Project Abstract Testicular cancer diagnosis and treatment, especially given its threat to sexuality and reproductive health, can be distressing in the formative period of young ad...

$6.73M
USD
Active NON-SBIR/STTR RPGS
Dual targeting of PI3K and NOS pathways in Metaplastic BreastCancer (MBC)
NATIONAL CANCER INSTITUTE Methodist Hospital Research Institute United States 2023 – 2028

ABSTRACT Metaplastic breast cancer (MpBC) is a rare subset accounting for

$6.44M
USD
Completed NON-SBIR/STTR RPGS
Understanding Treatment Tolerability in Older Patients with Cancer
NATIONAL CANCER INSTITUTE University of Rochester United States 2023 – 2024

PROJECT SUMMARY The overarching goal of this grant proposal supplement, submitted on behalf of the University of Rochester NCI Community Oncology Research Program (UR NCORP) Resear...

$3.5M
USD
Completed NON-SBIR/STTR RPGS
Analyzing and Interpreting PRO-CTCAE with CTCAE and Other Clinical Data to Characterize Drug Tolerability
NATIONAL CANCER INSTITUTE University of North Carolina Chapel Hill United States 2023 – 2024

PROJECT ABSTRACT In cancer clinical trials, it is essential to understand and communicate the negative impact of drugs on patient participants in order to balance risks and benefit...

$2.69M
USD